Publications by authors named "Manzur A"

Background: Prior to the introduction of disease-modifying treatments (DMTs), children with type 1 spinal muscular atrophy (SMA) typically did not survive beyond the age of 2 years; management was mainly palliative. Novel therapies have made this a treatable condition, resulting in increased life expectancy and more time spent upright. Survival and improved function mean spinal asymmetry is a new complication with limited data on its prevalence and severity and no current guidelines on management and treatment.

View Article and Find Full Text PDF

Obstructive Sleep Apnoea (OSA) is associated with the development of cardiovascular disease (CVD); however, the risk is only weekly related to OSA severity traditionally determined by the apnoea-hypopnoea index. The Baveno classification was developed to improve patient selection who would benefit from OSA treatment in terms of symptoms improvement and CVD risk reduction. However, it is unclear how the classification relates to biomarkers of CVD risk.

View Article and Find Full Text PDF
Article Synopsis
  • The NorthStar Ambulatory Assessment (NSAA) total score (TS) is used to track disease progression and treatment effects in children with Duchenne Muscular Dystrophy (DMD).
  • This study analyzes TS performance patterns in young individuals, focusing on their walking/running and rising abilities, and compares trends in those whose condition is stable versus declining.
  • The findings aim to enhance clinical management by linking TS trends to therapy standards, helping families and therapists make informed treatment decisions.
View Article and Find Full Text PDF
Article Synopsis
  • Short bowel syndrome is a rare condition with limited existing data, prompting a registry study in Latin America focused on chronic intestinal failure, analyzing various patient and clinical factors from specialized centers.
  • From May 2020 to July 2023, the study included 167 patients (115 adults and 52 children) across 20 centers, revealing key demographics, complications, and outcomes, with significant differences between adults and children in terms of etiology and follow-up results.
  • The findings aim to enhance understanding of intestinal failure in Latin America, serving as both a data repository and an educational resource for healthcare teams, while striving for international recognition of regional health challenges.
View Article and Find Full Text PDF

Background And Purpose: Treatment with glucocorticoids (GCs) is part of the standard of care in Duchenne muscular dystrophy, but excess weight gain and height stunting are common side-effects. It is still unclear how these growth-related side-effects affect motor function.

Methods: This retrospective cohort study utilized 2228 observations from 648 participants in the UK NorthStar database who had growth and ambulation data recorded between 2006 and 2020.

View Article and Find Full Text PDF
Article Synopsis
  • - This study investigates the effects of scoliosis surgery on various outcomes (respiratory function, motor function, weight, pain, and patient satisfaction) in patients with spinal muscular atrophy (SMA), highlighting the lack of research on these secondary outcomes.
  • - Results showed significant improvement in respiratory function for SMA2 patients postsurgery, but some experienced drops in gross motor scores and weight, with many reporting postsurgical pain, especially hip-related.
  • - Despite these challenges, patients and parents expressed overall satisfaction with the surgery's impact on posture and appearance, emphasizing the need for better postoperative care, including physiotherapy and support services.
View Article and Find Full Text PDF

The invasive mucinous adenocarcinoma of the lungs (LIMA) is an uncommon histological subtype of the mucinous adenocarcinoma. In this article, we present the case of a patient with a very high cardiovascular risk profile, diagnosed with LIMA, pericardial tamponade due to secondary dissemination, and pulmonary embolism, whose management rouses many challenges. Despite receiving the correct anticoagulant and antiaggregant therapy, our patient developed repeated acute major cardiovascular events leading to a fatal outcome.

View Article and Find Full Text PDF
Article Synopsis
  • Spinal muscular atrophy (SMA) is a genetic disorder leading to muscle weakness due to mutations in the SMN1 gene.* -
  • Onasemnogene abeparvovec (OA) is a gene therapy approved for SMA that was administered to two heavy patients (20 kg) previously treated with another medication, Nusinersen.* -
  • The patients experienced mixed results after receiving OA, including liver issues needing steroids and limited improvement in muscle function, highlighting the importance of weighing risks and benefits for older and heavier SMA patients.*
View Article and Find Full Text PDF

Evaluations of treatment efficacy in Duchenne muscular dystrophy (DMD), a rare genetic disease that results in progressive muscle wasting, require an understanding of the 'meaningfulness' of changes in functional measures. We estimated the minimal detectable change (MDC) for selected motor function measures in ambulatory DMD, i.e.

View Article and Find Full Text PDF

This large, multicenter, retrospective cohort study including onco-hematological neutropenic patients with bloodstream infection (PABSI) found that among 1213 episodes, 411 (33%) presented with septic shock. The presence of solid tumors (33.3% vs.

View Article and Find Full Text PDF

Aim: Hypertension and diabetes mellitus (DM) are major causes of morbidity and mortality, with growing burdens in low-income countries where they are underdiagnosed and undertreated. Advances in machine learning may provide opportunities to enhance diagnostics in settings with limited medical infrastructure.

Materials And Methods: A non-interventional study was conducted to develop and validate a machine learning algorithm to estimate cardiovascular clinical and laboratory parameters.

View Article and Find Full Text PDF

Quantitative muscle fat fraction (FF) responsiveness is lower in younger Charcot-Marie-Tooth disease type 1A (CMT1A) patients with lower baseline calf-level FF. We investigated the practicality, validity, and responsiveness of foot-level FF in this cohort involving 22 CMT1A patients and 14 controls. The mean baseline foot-level FF was 25.

View Article and Find Full Text PDF

Background: Despite advancements in coronary artery bypass grafting (CABG), the optimal choice of graft material remains a subject of investigation. This study aimed to comprehensively analyze the morphological characteristics of varicose veins, exploring their potential utilization in CABG compared to healthy veins.

Methods: The study included 178 patients, categorized into two groups based on healthy and varicose veins.

View Article and Find Full Text PDF

In digenic inheritance, pathogenic variants in two genes must be inherited together to cause disease. Only very few examples of digenic inheritance have been described in the neuromuscular disease field. Here we show that predicted deleterious variants in SRPK3, encoding the X-linked serine/argenine protein kinase 3, lead to a progressive early onset skeletal muscle myopathy only when in combination with heterozygous variants in the TTN gene.

View Article and Find Full Text PDF

Background: Real-world data on the efficacy and safety of onasemnogene abeparvovec (OA) in spinal muscular atrophy (SMA) are needed, especially to overcome uncertainties around its use in older and heavier children. This study evaluated the efficacy and safety of OA in patients with SMA type 1 in the UK, including patients ≥2 years old and weighing ≥13.5 kg.

View Article and Find Full Text PDF

Unlabelled: Background Boys with Duchenne Muscular Dystrophy (DMD) display heterogeneous motor function trajectory in clinics, which represents a significant obstacle to monitoring.

Objective: In this paper, we present the UK centiles for the North Star Ambulatory Assessment (NSAA), the 10 m walk/run time (10MWR) and velocity (10MWRV), and the rise from floor time (RFF) and velocity (RFFV) created from a cohort of glucocorticoid treated DMD boys between the age of 5 and 16 years.

Methods: Participants were included from the UK NorthStar registry if they had initiated steroids (primarily deflazacorts/prednisolone, intermittent/daily) and were not enrolled in an interventional trial.

View Article and Find Full Text PDF
Article Synopsis
  • Whole genome sequencing (WGS) is being increasingly used to diagnose rare diseases, but traditional methods often have low diagnostic yields, typically 25-30%.
  • In a study involving 122 rare disease patients and their relatives, a comprehensive bioinformatics approach led to a diagnostic yield of 35%, with 39% solved when including novel gene candidates.
  • The study also identified several novel genes, expanded the phenotypic understanding of existing conditions, and resulted in critical changes to clinical diagnoses and treatments for some patients.
View Article and Find Full Text PDF

Background And Objectives: -related myopathies are the most common congenital myopathies, but long-term natural history data are still scarce. We aim to describe the natural history of dominant and recessive -related myopathies.

Methods: A cross-sectional and longitudinal retrospective data analysis of pediatric cases with -related myopathies seen between 1992-2019 in 2 large UK centers.

View Article and Find Full Text PDF

Background: Nocturnal hypoxaemia measured as the percentage of total sleep time spent with saturation below 90% (TST90%) may better predict cardiovascular consequences of obstructive sleep apnoea (OSA) than the number of obstructive respiratory events measured with the apnoea-hypopnea index (AHI). Deeper hypoxaemia may potentially induce more severe pathophysiological consequences. However, the additional value of the percentage of total sleep time spent with saturation below 80% (TST80%) to TST90% is not fully explored.

View Article and Find Full Text PDF
Article Synopsis
  • The North Star ambulatory assessment (NSAA) is a key measure for tracking motor function in boys with Duchenne muscular dystrophy (DMD), but the minimal clinically important difference (MCID) for NSAA is not well-established, complicating result interpretation.
  • This study aimed to estimate the MCID for NSAA using various methods, including statistical approaches and patient/parent feedback, resulting in estimates of 2.3-3.5 points for boys aged 7 to 10 years.
  • Findings highlighted that patients and parents view a complete loss of function in one item or a decline in one to two items as significant changes, enhancing the understanding of clinical relevance in NSAA results.
View Article and Find Full Text PDF

The aims of our study were to use whole genome sequencing in a cross-sectional cohort of patients to identify new variants in genes implicated in neuropathic pain, to determine the prevalence of known pathogenic variants and to understand the relationship between pathogenic variants and clinical presentation. Patients with extreme neuropathic pain phenotypes (both sensory loss and gain) were recruited from secondary care clinics in the UK and underwent whole genome sequencing as part of the National Institute for Health and Care Research Bioresource Rare Diseases project. A multidisciplinary team assessed the pathogenicity of rare variants in genes previously known to cause neuropathic pain disorders and exploratory analysis of research candidate genes was completed.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical trials for Duchenne muscular dystrophy (DMD) typically use genotype-matched controls, which complicates patient enrollment due to this rare disease's limited pool.
  • The study analyzed over 1,600 patient-years from multiple sources to understand the impact of different genotype classes on motor function changes over a year.
  • Results indicated that genotype only accounted for about 2% of variation in motor function outcomes, suggesting that utilizing unmatched controls in trials could be a viable option.
View Article and Find Full Text PDF
Article Synopsis
  • - Primary acetylcholine receptor (AChR) deficiency is the most common form of congenital myasthenic syndrome, leading to fewer acetylcholine receptors at muscle endplates and poor neuromuscular communication.
  • - A study identified a specific CHRNA1 genetic variant (p.Arg86His) in 13 patients, linked to the production of a non-functional AChR α-subunit, deviating from typical symptoms seen in other AChR deficiency cases.
  • - Clinical symptoms showed unusual facial and upper limb weakness in adulthood, prompting a recommendation to consider alternative exons during genetic analyses for better diagnosis.
View Article and Find Full Text PDF

Objectives: To assess the clinical features and outcomes of Pseudomonas aeruginosa bloodstream infection (PA BSI) in neutropenic patients with hematological malignancies (HM) and with solid tumors (ST), and identify the risk factors for 30-day mortality. Methods: We performed a large multicenter, retrospective cohort study including onco-hematological neutropenic patients with PA BSI conducted across 34 centers in 12 countries (January 2006−May 2018). Episodes occurring in hematologic patients were compared to those developing in patients with ST.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers conducted a retrospective analysis involving 134 DMD patients, comparing their forced vital capacity (FVC) with sleep study results, identifying various levels of NH and obstructive sleep apnea (OSA).
  • * Results indicated that while FVC <50% is correlated with NH, some patients with FVC >50% still showed NH, highlighting the complex relationship between lung function and sleep apnea in DMD patients.
View Article and Find Full Text PDF